Previous optical coherence tomography (OCT) study reported that irregular protrusion (IP) post drugeluting stent (DES) implantation was an independent predictor of clinical outcome; however, the relationship between IP and the presence of subsequent in-stent neoatherosclerosis remains unclear. This study aimed to assess the relationship between IP and in-stent neoatheroscrerosis formation using OCT. We evaluated 83 patients (101 lesions) who underwent second-generation DES implantation and 8-month follow-up (8M-FU) using OCT. Lesions were divided into two groups in presence of IP (IP: n = 43, non-IP: n = 58). At prepercutaneous coronary intervention (pre-PCI), lipid-rich plaque, lesions with positive remodeling, and in-stent thrombus formation were more frequent in IP than in non-IP. On multivariate analysis, the thrombus at pre-PCI and the lesions with positive remodeling were independent predictors of IP. At 8M-FU, heterogeneous neointima, microvessel, lipidladen neointima, and thin-cap fibro-atheroma like neointima were more frequent in IP than in non-IP (respectively, P < 0.05). On multivariate analysis, IP was associated with heterogeneous neointima. Binary restenosis was more frequent and late lumen loss tended to be larger in IP than in non-IP (19% versus 5%, P = 0.04; 1.25 ± 1.24 mm versus 0.91 ± 0.63 mm, P = 0.09); however, the target lesion revascularization rate was similar in both groups at 8M-FU. In conclusion, our study suggested that poststent IP was associated with subsequent neoatherosclerosis formation at 8M-FU after the second-generation DES implantation.
T issue protrusion (TP) is commonly defined as tissue extrusion through stent struts after stent implantation. TP is detectable more frequently by intravascular ultrasound (IVUS) than coronary angiography alone; however, the clinical impact of TP detected by IVUS is controversial. [1] [2] [3] Optical coherence tomography (OCT) has a 10-fold higher resolution than IVUS, and OCT detects TP more clearly and frequently. Several OCT studies have reported that TP was not associated with the cardiac events; [4] [5] [6] however, a recent OCT study revealed that irregular protrusion (IP) was an independent predictor of 1-year clinical adverse outcome, in particular, target lesion revascularization (TLR). 7) Notably, IP represented moderate to severe vessel injury with a high likelihood of medial disruption and lipid core penetration. A previous study reported that the lipid core penetration and deep vessel injury by stent implantation may cause arterial inflammation and thrombogenicity, thereby increase the risk for early stent thrombosis and stent restenosis. 8) Consequently, the stented lesion with IP detected by OCT may lead to unfavorable in-stent healing course. Alternatively, late stent failure remains a concern following stent placement, despite the development of newer-generation drug-eluting stent (DES). In-stent neoatherosclerosis has emerged as an important contributing factor to late target lesion failure including TLR; 9) however, there has been no report about the contribution of IP after DES implantation to the instent neoatherosclerosis. In the present study, we performed a serial OCT examination to assess the relationship between IP after second-generation DES implantation and subsequent in-stent neoatherosclerosis at 8M-FU.
Methods

Study population:
This was a retrospective study conducted in our institution from January 2012 to December 2016. We performed serial coronary angiography with OCT evaluation at baseline and 8M-FU in patients who underwent second-generation DES implantation. The fol-Sanuki, ET AL lowing exclusion criteria were used: 1) chronic total occlusion; 2) in-stent restenotic lesion; 3) patients with moderate to severe renal dysfunction, except hemodialysis; and 4) no serial OCT data and/or poor OCT image quality. Stent implantation was performed using the present conventional techniques. The interventional strategy was left to the discretion of the operator. Optimal DES expansion was performed according to "AVIO criteria" (70 ± 10% of the cross-sectional area of the inflated balloon used to postdilate the stent). 10) All patients received dual antiplatelet therapy with aspirin (100 mg/day) plus clopidogrel (75 mg/day) or prasugrel (3.75 mg/day) for at least 8-months after stent implantation. Acute coronary syndrome (ACS) included ST-elevation myocardial infarction, non-ST-segment elevation myocardial infarction, and unstable angina. Stable angina was defined as the predictable pattern of chest pain that most often occurs with activity or emotional stress. This study was performed in accordance with the Declaration of Helsinki for investigations in humans and all enrolled patients provided their written informed consent before the cardiac catheterization. OCT image acquisition: OCT evaluation was performed before and after the percutaneous coronary intervention (PCI) and at 8M-FU. OCT was performed with the frequency-domain OCT (FD-OCT) system (C7/C8 system; St. Jude Medical, St. Paul, MN, USA), or the optical frequency-domain system (OFDI, Lunawave system; Terumo, Tokyo, Japan). Intracoronary nitroglycerine was administered before commencing the intracoronary imaging procedure. An OCT imaging catheter was placed advanced distal to the stenotic lesion over a conventional guidewire and was automatically pulled back at 20-40 mm/s. Contrast media was continuously infused from the tip of the guiding catheter during the pull back. We basically used the same OCT system for serial examination to achieve optimal consistency. OCT image analysis: Qualitative evaluation was performed at the cross-section level with 1-mm interval. According to the definition in a previous study, 7) we categorized the TP at post-PCI into three groups: smooth protrusion, disrupted fibrous TP, and IP. Smooth protrusion was defined as the bowing of a plaque into the lumen between the stent struts without an intimal disruption. Disrupted fibrous TP was defined as the disruption of the underlying fibrous TP into the lumen between the stent struts. IP was defined as protrusion of the material with an irregular surface into the lumen between the stent struts by OCT. When the stent struts were buried within the intima, instent protrusions with maximal height " 100 μm were included into IP (Figure 1 ). If the materials on the stent struts could not be distinguished as thrombus or IP, they were categorized as IP.
Lipid-rich plaque at pre-PCI and lipid-laden neointima at 8M-FU was defined as a signal-poor region with diffused borders and an angle "90°. TCFA was defined as the fibrous cap thickness at the thinnest part !65 μm and an angle of lipid tissue "180°. Plaque calcification was defined as a well-delineated, single poor region with sharp borders. Thrombi were masses protruding into the vessel lumen with high backscattering and attenuation (red thrombi) or with homogeneous backscattering and low attenuation (white thrombi) that were discontinuous from the surface of the vessel. [11] [12] [13] Stent edge dissection was defined as the arterial disruption with a visible flap at the stent edge. Incomplete stent apposition was defined as one or more stent struts that clearly separated from the inner vessel wall, in segments without a side branch. Incomplete stent apposition length was higher than the sum of the strut thickness plus polymer thickness and a compensation factor of 20 μm to correct for strut blooming.
Neointimal tissue was classified as follows: 1) homogeneous neointima, a uniform signal-rich band without focal variation or attenuation; 2) heterogeneous neointima, focally changing optical properties and various backscattering pattern; or 3) layered neointima, layers with an adluminal high-scattering layer and an abluminal lowscattering layer. 14) A microvessel was defined as a small vesicular or tubular structure with a diameter !200 μm. 15) Neointimal rupture was a break in the fibrous cap that connected the lumen with the underlying lipid pool. The definition of neoatheroscrelosis included lesions with heterogeneous neointima, lipid-laden neointima, neointima with calcification, TCFA-like neointima, or neointimal rupture. 9, 12, 13) Quantitative analyses calculated the mean reference area, mean reference diameter, minimal stent area (MSA), and % stent expansion (defined as MSA divided by mean reference area). We divided the lesions into those with positive remodeling (defined as culprit lesion vessel di- ameter > proximal reference lesion vessel diameter) and those without positive remodeling (nonpositive remodeling). If the vessel circumference was not visible, we used a circular approximation with the algorithm of vessel circumference. 16) Nonpositive remodeling included lesions with absence of remodeling, negative remodeling, or lesions that could not be measured for vessel circumference using the algorithm due to the entire circumference of calcium or lipid. Minimal lumen area (MLA) at stented lesions and late lumen loss (defined as MSA minus MLA) at follow-up, were analyzed.
All OCT images were analyzed by two investigators (Y.S and Y.M) who were blinded to the clinical presentation and the lesion and procedure characteristics. When there was discordance between the readers, consensus reading was obtained from a third investigator (S.S). Coronary angiographic and clinical follow-up: Binary restenosis on coronary angiography and TLR were evaluated at 8M-FU. Quantitative coronary angiography (QCA) was performed using an offline QCA system (CAAS QCA for Research 2.0, Pie Medical Imaging BV, Netherlands). Binary restenosis was defined as a percentage diameter restenosis !50% on QCA. TLR was defined as any intervention (surgical or percutaneous) of the stented lesion. Statistical analysis: All continuous variables were presented as the mean ± standard deviation (SD). All categorical variables were presented as counts and percentages. Differences between any two groups were assessed with the chi-square test for comparisons of categorical variables, and nonparametric Mann-Whitney U test for continuous variables. To determine the independent predictors of IP, a logistic regression model was used. Certain variables, which exhibited a statistical significance of P < 0.1 after univariate analysis, were included in the multivariate regression. The association between IP and each finding at the 8M-FU was summarized as an OR (odds ratio) estimated by the multivariate logistic regression analysis. A P value < 0.05 was considered to indicate statistical significance. Statistical analysis was performed using JMP version 9.0 (SAS Institute Inc., Cary, North Carolina, USA).
Results
A total of consecutive 139 patients with 172 lesions underwent OCT-monitored second-generation DES implantation from January 2012 to June 2016. Fifty-six patients with 71 lesions were excluded because the followup examinations were not performed due to any reason (29 lesions), follow-up examinations were performed without OCT (19 lesions), or the absence of serial OCT images and/or poor OCT image quality captured at pre-, post-PCI, and follow-up (23 lesions; Figure 2 ). Therefore, a total of 83 patients with 101 lesions (ACS: n = 5, stable angina pectoris: n = 96) were enrolled in this study. At baseline, 21 lesions were assessed by FD-OCT and 80 lesions were assessed by OFDI. We basically used the same OCT system for serial examination. Coexisting dyslipidemia and statin usage were more frequent in the included patients than in the excluded patients; however, no significant differences were observed in any other baseline characteristics between both types of patients. Of all the 101 lesions, in-stent TP was observed in 92.1% (93/101 lesions). The occurrences of IP, smooth protrusion, and disrupted fibrous TP were 42.6% (43/101 lesions), 54.5% (55/101 lesions), and 42.6% (43/101 lesions), respectively. Lesions were divided into two groups in presence of IP (IP: n = 43, non-IP: n = 58). Baseline characteristics: Baseline characteristics are listed in Table I . Patients with a previous history of myocardial infarction and angiotensin converting enzyme inhibitor (ACE-I) or angiotensin II receptor blocker (ARB) usage were more common in IP than in non-IP. No sig-Sanuki, ET AL Values are mean ± SD or n (%). HDL indicates high-density lipoprotein; LDL, low-density lipoprotein; eGFR, estimated glomerular filtration rate; PCI, percutaneous coronary intervention; ACE-I, angiotensin-converting enzyme inhibitor; and ARB, angiotensin II receptor blocker.
nificant differences were observed between the groups in other baseline characteristics. ACS tended to be more frequent in IP than in non-IP (9% versus 2%, P = 0.08).
OCT findings: OCT findings at pre-and post-PCI are listed in Table II . Lipid-rich plaque, pre-PCI thrombi, instent thrombi, and lesion with positive remodeling were more frequent in IP than in non-IP (respectively, P < 0.05). Background plaque characteristics of 43 IP lesions at pre-PCI were as following; lipid-rich plaque 58.1%, fibrous plaque 4.7%, fibrocalcific plaque 9.3%, calcified plaque 27.9%, TCFA 18.6%, and thrombus 34.9%. OCT findings at 8M-FU are listed in Table III . Heterogeneous neointima, microvessels, lipid-laden neointima, and TCFA-like neointima were found in the stented segments of IP more frequently than that of non-IP (respectively, P < 0.05). Late lumen loss tended to be larger in IP than in non-IP. The incidence of neoatheroscrelosis in this study was 26.7% (27/101 lesions). Furthermore, the ratio of neoatherosclerosis in IP was significantly higher than that in non-IP (53% versus 7%, P < 0.001).
Representative OCT images of the stented lesions obtained after PCI and at 8M-FU are presented in Figure 3 . No significant differences were observed in the follow-up OCT findings among the stents. Angiographic and clinical follow-up: Overall, the binary restenosis and TLR occurred in 10.9% (11 lesions) and 6.9% (7 lesions) cases, respectively. Binary restenosis occurred significantly more often in IP than in non-IP (18.6% versus 5.2%, P = 0.03), whereas the incidence of TLR at 8M-FU was similar between IP and non-IP (7.0% versus 5.2%, P = 0.71; Figure 4 ). Predictors for IP: Independent predictors of IP at pre-PCI are summarized in Table IV . Medical history of myocardial infarction, ACE-I/ARB usage, ACS, lipid-rich plaque, thrombus, and lesion with positive remodeling at pre-PCI were correlated with IP. On multivariate analysis, thrombus and positive remodeling were independent predictors of IP (Table IV) .
Contribution of IP at 8M-FU:
Uncovered struts, heterogeneous neointima, microvessels, lipid-laden neointima, thrombus, TCFA-like neointima, late lumen loss at OCT findings, and binary restenosis were correlated with IP. On IRREGULAR PROTRUSION AND NEOATHEROSCLEROSIS Values are mean ± SD or n (%). PCI indicates percutaneous coronary intervention; TCFA, thin cap fibroatheroma; and MSA, minimal stent area. Values are mean ± SD or n (%). OCT indicates optical coherence tomography; and TCFA, thin-cap fibroatheroma.
multivariate analysis, heterogeneous neointima was associated with IP (Table V) . Predictive values of IP for heterogeneous neointima were as following: sensitivity of 82.6%, specificity of 69.2%, positive predictive value of 44.2%, and negative predictive value of 93.1%.
Discussion
The main findings of this study were as follows: 1) IP was frequently observed in 43 of 101 lesions (42.6%) after the second-generation DES implantation, 2) thrombus and lesion with positive vessel remodeling at pre-PCI were independent predictors of IP, and 3) IP was associated with heterogeneous neointima at 8M-FU.
To date, several IVUS studies have reported that the incidence of TP was 17%-70% in patients with ACS, and 17%-31% in patients with stable angina. [1] [2] [3] Although some studies have reported that IVUS-detected TP was associated with periprocedural myocardial injury or early stent thrombosis, 2, 3) other studies have reported that TP was not associated with the mid-term clinical outcomes. 1, 2) OCT, which has a 10-fold higher resolution than IVUS, is more useful for evaluating TP after stent implantation. Therefore, TP is detectable more frequently by OCT than by IVUS. Several OCT studies reported that TP was found in over 90% of the stented lesions. [4] [5] [6] Although an OCT study reported that the TP volume was associated with creatine kinase-myocardial band elevation after stent implantation, most of the OCT studies reported that TP detected by OCT was not associated with the mid-term adverse clinical events. In the present study, TP was detected in 92.1% (93/101 lesions), which is similar to the previous OCT studies. As a result, the relationship between TP and adverse cardiac event was controversial in the IVUS and OCT studies.
Alternatively, OCT enables us to assess the TP morphology more clearly with its high resolution than IVUS. Recently, Soeda, et al., characterized TP into three types Sanuki, ET AL Incidence of binary restenosis and TLR at 8-month follow-up. A: Overall, binary restenosis, defined as percentage diameter stenosis > 50%, occurred in 11 of 101 lesions (10.9%). The incidence of binary restenosis was significantly higher in IP than in non-IP (18.6% versus 5.2%, P = 0.03). B: Overall, TLR occurred in 7 of 101 lesions (6.9%). The incidence of TLR was similar between the groups (7.0% versus 5.2%, P = 0.71).
in their OCT study: smooth protrusion, disrupted fibrous tissue protrusion, and IP. 7) They described that IP represented more severe vessel injury than other protrusions with high likelihood of medial disruption and lipid core penetration, whereas smooth protrusion represented minimal vessel injury and disrupted fibrous tissue protrusion represented mild vessel injury. Previous pathological studies have reported that the increased vascular injury and penetration of the necrotic core of lipid-rich plaques were associated with increased neointimal growth, greater count of inflammatory cells, and thrombus formation. 8, 17) Another study has reported that lesions with greater stent length, greater percent atheroma volume on IVUS, and greater lipid content and higher prevalence of thrombus on OCT were identified as predictors for IP following stent implantation. 18) In this study, IP was detected in 42.6% lesions, which was slightly lesser than the study of Soeda, et al. (53.8%). Thrombus and positive vessel remodeling, which suggest the presence of vulnerable plaques, were independent predictors of IP, similar to the previous study.
Soeda, et al. also reported that IP was an independent predictor of 1-year clinical adverse outcome, in particular, TLR after bare metal stent, first-generation DES, and second-generation DES. In-stent neoatherosclerosis has emerged as an important contributing factor to late target lesion failure including TLR, even in secondgeneration DES era. 9, 19) Considering these facts, IP may associate with in-stent neoatherosclerosis.
Previous OCT studies defined neoatherosclerosis on OCT as lipid-laden neointima, neointima with calcification, TCFA-like neointima, or neointimal rupture.
12) The occurrence of neointima with calcification, TCFA-like neointima, and neointimal rupture was considerably lesser after the second-generation DES implantation, similar to the previous study. 13) Other studies demonstrated that neointima rich in smooth muscle cells and collagen fibers IRREGULAR PROTRUSION AND NEOATHEROSCLEROSIS exhibited high-optical intensity, whereas neointima rich in proteoglycans, myxomatous tissue, fibrin, inflammatory changes, and thrombi exhibited a low optical intensity on OCT. 14, 20) Fibrin deposits and inflammatory cells are associated with delayed vascular healing after DES implantation. It is presumed that accelerated neoatherosclerosis after DES implantation occurs following delayed vascular healing. 9, 14) In this study, IP was associated with heterogeneous neointima and tended to be associated with lipidladen neointima after second-generation DES implantation. Overall, the binary restenosis and TLR rate were 10.9% and 6.9%. After dividing the lesions into IP and non-IP, a considerable difference was observed between binary restenosis and TLR in the IP group. We deferred PCI if the patient revealed intermediate stenosis without evident ischemia; however, intermediate stenoses in IP were associated with neoatherosclerotic findings by OCT. A previous pivotal study reported that the TLR rate after everolimus-eluting stent implantation stepped-up without attenuation up to 5 years, 21) which might associate with neoatherosclerosis. A period of 8-month may be shorter for follow-up. Therefore, we should carefully follow-up for IP lesions, because neoatherosclerosis may lead to future adverse cardiac events, in particular, late TLR. Moreover, the considerable difference of binary restenosis and TLR in IP at 8-month might be lost in future.
Eventually, we have no data on treatment strategies if IP is detected on OCT at post-DES implantation. In this study, we performed optimal DES expansion. MSA after DES implantation was similar between both groups; however, neoatherosclerosis occurred more frequently in IP than in non-IP. Therefore, it may be difficult to prevent neoatherosclerosis by the present PCI technique to reduce IP. A previous study demonstrated that intensive lowdensity lipoprotein cholesterol (LDL-C) lowering therapy including high-dose statin caused favorable on neointimal tissue characteristics after second-generation DES implantation. 22) Furthermore, intensive LDL-C lowering therapy with combined lipid-lowering drugs (ezetimibe, and proprotein convertase subtilisin kexin 9 inhibitors) and risk factor control may be required to prevent future adverse events when IP is found on OCT. 23, 24) Study limitations: Notably, the present study has several limitations. First, because the present study was a singlecenter, retrospective study, selection bias may have occurred. Second, on OCT, the present analysis did not include patients with moderate to severe renal dysfunction except hemodialysis. Third, the definition of IP using OCT is novel and has not yet been validated. Fourth, the prevalence of ACS was low in this study (5%), because we mainly used IVUS in the case of ACS. This was the reason of low incidence of IP compared with the study of Soeda, et al. 7) Fifth, we did not conduct validation studies comparing FD-OCT with OFDI; however, the previous study demonstrated excellent quantitative precision between FD-OCT and OFDI. 25) Furthermore, the histopathological correlative studies of each OCT device have been conducted, revealing good correspondences between each OCT findings and histopathological findings. 26) We presumed that both OCT devices had quantitative and qualitative precision equivalently. Eventually, although we performed 8-month follow-up CAG with OCT, the 8-month time frame might be insufficient for assessing the relationship between in-stent neoatherosclerosis and TLR. Therefore, we need a larger population and prospective serial observational study to verify the results of this study.
Conclusions
The presence of IP after second-generation DES implantation was associated with subsequent neoatheroscle-Sanuki, ET AL rosis formation at 8M-FU.
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